# Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC

> **NCT03953443** · — · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 25 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **OTHER:** Not interventional

## Key facts

- **NCT ID:** NCT03953443
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-17
- **Primary completion:** 2020-02-13
- **Final completion:** 2023-03-14
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953443, "Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03953443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*